Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6.

Genetic alterations of the BCL-6 gene in mice and man have established BCL-6 as a pivotal regulator of normal differentiation of B and T lymphocytes as well as one of the most frequently translocated oncogenes in human B cell lymphomas. As an oncogene, BCL-6 has not been easy to place into existing paradigms of cellular transformation. Rather, it is likely that the function of BCL-6 as a regulator of lymphocyte differentiation is subverted in BCL-6-induced lymphomas. The lymphomas in which BCL-6 is translocated are all suspected to arise from the germinal center B lymphocyte. Given the selective expression of BCL-6 protein in normal germinal center B lymphocytes and the requirement for BCL-6 in germinal center development, the functions of BCL-6 in normal and malignant B cells are probably intertwined. The BCL-6 protein is a potent transcriptional repressor which presumably controls lymphocyte differentiation and induces lymphomas by regulating the expression of key downstream target genes.

[1]  G. Kollias,et al.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.

[2]  S. Akira,et al.  Essential role of Stat6 in IL-4 signalling , 1996, Nature.

[3]  W. Paul,et al.  Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene , 1996, Nature.

[4]  D. Leprince,et al.  The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[5]  A. Dejean,et al.  SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia , 1997 .

[6]  D. Leprince,et al.  Multiple domains participate in distance-independent LAZ3/BCL6-mediated transcriptional repression. , 1996, Biochemical and biophysical research communications.

[7]  S. Pileri,et al.  Detection of BCL‐6 rearrangements and p53 mutations in malt‐lymphomas , 1997, American journal of hematology.

[8]  N. Aoki,et al.  Variant Translocation of the BCL6 Gene to Immunoglobulin k Light Chain Gene in B‐Cell Lymphoma , 1994, Japanese journal of cancer research : Gann.

[9]  David D. Chaplin,et al.  Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal Centers , 1996, Science.

[10]  M. Kaplan,et al.  Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. , 1998, Journal of immunology.

[11]  M. Kaplan,et al.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. , 1996, Immunity.

[12]  F. Karch,et al.  The Trithorax-like gene encodes the Drosophila GAGA factor , 1994, Nature.

[13]  S. Pittaluga,et al.  BCL6 gene rearrangements also occur in marginal zone B‐cell lymphoma , 1997, British journal of haematology.

[14]  R. DePinho.  Transcriptional repression: The cancer-chromatin connection , 1998, Nature.

[15]  G. Gaidano,et al.  Point mutations of the BCL‐6 gene in Burkitt's lymphoma , 1997, British journal of haematology.

[16]  N. Takahashi,et al.  Rearrangements of the BCL6 gene and chromosome aberrations affecting 3q27 in 54 patients with non-Hodgkin's lymphoma. , 1997, Leukemia & lymphoma.

[17]  S. Elgin,et al.  Chromatin: Ga-ga over GAGA factor , 1995, Current Biology.

[18]  C. Tribioli,et al.  Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL , 1998, Nature Genetics.

[19]  G. Kelsoe.  In situ studies of the germinal center reaction. , 1995, Advances in immunology.

[20]  Klaus Rajewsky,et al.  Somatic hypermutation in normal and transformed human B cells , 1998, Immunological reviews.

[21]  E. Puré,et al.  T-independent and T-dependent B lymphoblasts: helper T cells prime for interleukin 2-induced growth and secretion of immunoglobulins that utilize downstream heavy chains , 1991, The Journal of experimental medicine.

[22]  M. Hatano,et al.  The murine BCL6 gene is induced in activated lymphocytes as an immediate early gene. , 1995, Oncogene.

[23]  G. Gaidano,et al.  Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. , 1997, Blood.

[24]  N. Zeleznik-Le,et al.  BCL6 can repress transcription from the human immunodeficiency virus type I promoter/enhancer region , 1997, Genes, chromosomes & cancer.

[25]  M. Hatano,et al.  Disruption of the Bcl6 Gene Results in an Impaired Germinal Center Formation , 1997, The Journal of experimental medicine.

[26]  K. Calame,et al.  The ZiN/POZ domain of ZF5 is required for both transcriptional activation and repression. , 1997, Nucleic acids research.

[27]  R. Sauer,et al.  Transcription factors: structural families and principles of DNA recognition. , 1992, Annual review of biochemistry.

[28]  U. Storb,et al.  Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. , 1998, Science.

[29]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[30]  Laurie H Glimcher,et al.  The Proto-Oncogene c-maf Is Responsible for Tissue-Specific Expression of Interleukin-4 , 1996, Cell.

[31]  S. Mori,et al.  Regulation of BCL-6 gene expression in human myeloid/monocytoid leukemic cells , 1997, Leukemia.

[32]  R. Treisman,et al.  The POZ domain: a conserved protein-protein interaction motif. , 1994, Genes & development.

[33]  S. Romagnani.  Lymphokine production by human T cells in disease states. , 1994, Annual review of immunology.

[34]  L. Cooley,et al.  Kelch encodes a component of intercellular bridges in Drosophila egg chambers , 1993, Cell.

[35]  F. Mandelli,et al.  Pathogenetic and clinical implications of Bcl‐6 and Bcl‐2 gene configuration in nodal diffuse large B‐cell lymphomas , 1997, The Journal of pathology.

[36]  R. Gascoyne,et al.  Frequent association of t(3;14) or variant with other lymphoma‐specific translocations , 1995, British journal of haematology.

[37]  J. Ihle.  STATs: Signal Transducers and Activators of Transcription , 1996, Cell.

[38]  A. Rao,et al.  Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1. , 1997, Immunity.

[39]  S. Pileri,et al.  Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. , 1996, Blood.

[40]  Carl Wu,et al.  ATP-dependent nucleosome disruption at a heat-shock promoter mediated by binding of GAGA transcription factor , 1994, Nature.

[41]  R S Chaganti,et al.  BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Privé,et al.  The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Chaganti,et al.  Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. , 1995, The EMBO journal.

[44]  W. Paul,et al.  Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, Annual review of immunology.

[45]  K Offit,et al.  Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. , 1993, Science.

[46]  H. Tilly,et al.  TTF, a gene encoding a novel small G protein, fuses to the lymphoma-associated LAZ3 gene by t(3;4) chromosomal translocation. , 1995, Oncogene.

[47]  S. Inoue,et al.  Role of the histone deacetylase complex in acute promyelocytic leukaemia , 1998, Nature.

[48]  S. Iida,et al.  Heterologous Promoters Fused to BCL6 by Chromosomal Translocations Affecting Band 3q27 Cause Its Deregulated Expression During B-Cell Differentiation , 1998 .

[49]  L. Staudt,et al.  Control of inflammation, cytokine expression, and germinal center formation by BCL-6. , 1997, Science.

[50]  G. Crabtree,et al.  The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. , 1998, Immunity.

[51]  S. Mori,et al.  Expression of bcl‐6 protein in normal skin and epidermal neoplasms , 1997, Pathology international.

[52]  S. Akira,et al.  Abrogation of Bronchial Eosinophilic Inflammation and Airway Hyperreactivity in Signal Transducers and Activators of Transcription (STAT)6-deficient Mice , 1998, The Journal of experimental medicine.

[53]  S. Okabe,et al.  The BCL6 gene is predominantly expressed in keratinocytes at their terminal differentiation stage. , 1996, Biochemical and biophysical research communications.

[54]  P. H. Rao,et al.  Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. , 1993, Cancer research.

[55]  J. Licht,et al.  Sequence-specific DNA Binding and Transcriptional Regulation by the Promyelocytic Leukemia Zinc Finger Protein* , 1997, The Journal of Biological Chemistry.

[56]  R. Locksley,et al.  The regulation of immunity to Leishmania major. , 1995, Annual review of immunology.

[57]  S. Romagnani,et al.  The Th1/Th2 paradigm. , 1997, Immunology today.

[58]  H. Tilly,et al.  LAZ3, a novel zinc–finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas , 1993, Nature Genetics.

[59]  L. Staudt,et al.  Transcriptional repression by the proto-oncogene BCL-6. , 1996, Oncogene.

[60]  K. Offit,et al.  BCL-6 protein is expressed in germinal-center B cells. , 1995, Blood.

[61]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[62]  E. Jaffe,et al.  Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. , 1995, Blood.

[63]  A. Zelenetz,et al.  BCL6 gene rearrangement and other cytogenetic abnormalities in diffuse large cell lymphoma. , 1995, Leukemia & lymphoma.

[64]  W. Leonard,et al.  Jaks and STATs: biological implications. , 1998, Annual review of immunology.

[65]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[66]  F. Alt,et al.  CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[67]  C. Hsieh,et al.  T cell genetic background determines default T helper phenotype development in vitro , 1995, The Journal of experimental medicine.

[68]  M. Wills-Karp,et al.  Signal Transducer and Activator of Transcription Factor 6 (Stat6)-deficient Mice Are Protected from Antigen-induced Airway Hyperresponsiveness and Mucus Production , 1998, The Journal of experimental medicine.

[69]  D. Leprince,et al.  The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo. , 1995, Oncogene.

[70]  Martin Bachmann,et al.  Disruption of the murine IL-4 gene blocks Th2 cytokine responses , 1993, Nature.

[71]  J. O’Shea.  Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? , 1997, Immunity.

[72]  L. Staudt,et al.  T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[73]  T. Akiyama,et al.  BCL-6 is phosphorylated at multiple sites in its serine- and proline-clustered region by mitogen-activated protein kinase (MAPK) in vivo , 1997, Oncogene.

[74]  K. Offit,et al.  Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. , 1994, Blood.

[75]  M. Dyer,et al.  The B cell transcriptional coactivator BOB1/OBF1 gene fuses to the LAZ3/BCL6 gene by t(3;11)(q27;q23.1) chromosomal translocation in a B cell leukemia line (Karpas 231). , 1996, Leukemia.

[76]  P. Pandolfi,et al.  The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation , 1997, Nature Genetics.

[77]  M. Seto,et al.  BCL6 rearrangement in a patient with mantle cell lymphoma , 1997, Annals of Hematology.

[78]  E. Simpson,et al.  B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. , 1997, Immunity.

[79]  D. Carvajal,et al.  IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses , 1996 .

[80]  L. Glimcher,et al.  Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. , 1996, Immunity.

[81]  D. Chaplin,et al.  Lymphotoxin‐α‐deficient and TNF receptor‐I‐deficient mice define developmental and functional characteristics of germinal centers , 1997, Immunological reviews.

[82]  D. Leprince,et al.  Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[83]  N. Zeleznik-Le,et al.  BCL6 encodes a sequence‐specific DNA‐binding Protein , 1995, Genes, chromosomes & cancer.

[84]  Richard A Flavell,et al.  The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells , 1997, Cell.

[85]  R. Liang,et al.  Bcl‐6 gene hypermutations in diffuse large B‐cell lymphoma of primary gastric origin , 1997, British journal of haematology.

[86]  F. Alt,et al.  Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. , 1998, Immunity.

[87]  LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients , 1994 .

[88]  S. Mori,et al.  BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. , 1995, Blood.

[89]  M. Ladanyi,et al.  Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. , 1994, The New England journal of medicine.

[90]  N. Aoki,et al.  Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krüppel-like zinc-finger protein. , 1994, Blood.

[91]  L. Staudt,et al.  BCL-6 expression during B-cell activation. , 1996, Blood.

[92]  Chi-Wai Wong,et al.  Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein , 1998, Oncogene.

[93]  J. Darnell,et al.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.

[94]  M. Kaplan,et al.  Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice , 1996, Nature.

[95]  N. Aoki,et al.  Recognition DNA sequence of a novel putative transcription factor, BCL6. , 1994, Biochemical and biophysical research communications.

[96]  B. Falini,et al.  BCL-6 Protein Expression in Human Peripheral T-Cell Neoplasms Is Restricted to CD30+ Anaplastic Large-Cell Lymphomas , 1997 .

[97]  R. Liang,et al.  Mutation of the 5' noncoding region of the BCL-6 gene in low-grade gastric lymphoma of the mucosa-associated lymphoid tissue. , 1998, Cancer genetics and cytogenetics.

[98]  R. Liang,et al.  High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin. , 1997, Cancer genetics and cytogenetics.

[99]  W. Dietrich,et al.  Genetic Susceptibility to Leishmania: IL-12 Responsiveness in TH1 Cell Development , 1996, Science.

[100]  V. Sukhatme,et al.  Egr-1 expression in surface Ig-mediated B cell activation. Kinetics and association with protein kinase C activation. , 1990, Journal of immunology.